Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy
ClinicalTrials.gov study NCT04148430. IPD Sharing: YES. Countries: 1. Publications: 1.
Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
ClinicalTrials.gov study NCT00264849. IPD Sharing: Not stated. Countries: 17. Publications: 1.
A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata
ClinicalTrials.gov study NCT03570749. IPD Sharing: YES. Countries: 5. Publications: 9.
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs
ClinicalTrials.gov study NCT01578850. IPD Sharing: Not stated. Countries: 19. Publications: 3.
Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)
ClinicalTrials.gov study NCT01589185. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)
ClinicalTrials.gov study NCT03134222. IPD Sharing: NO. Countries: 2. Publications: 1.
Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients
ClinicalTrials.gov study NCT02424344. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
ClinicalTrials.gov study NCT03569293. IPD Sharing: YES. Countries: 25. Publications: 13.
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
ClinicalTrials.gov study NCT03535194. IPD Sharing: YES. Countries: 16. Publications: 1.
Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis
ClinicalTrials.gov study NCT00794664. IPD Sharing: Not stated. Countries: 6. Publications: 3.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
ClinicalTrials.gov study NCT04242446. IPD Sharing: YES. Countries: 15. Publications: 5.
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
ClinicalTrials.gov study NCT01623167. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients
ClinicalTrials.gov study NCT01646671. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01471171. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
ClinicalTrials.gov study NCT06220604. IPD Sharing: YES. Countries: 11. Publications: 1.
Topiramate in Adolescents With Severe Obesity
ClinicalTrials.gov study NCT01859013. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ABSORICA in Patients With Severe Recalcitrant Nodular Acne
ClinicalTrials.gov study NCT02457520. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
ClinicalTrials.gov study NCT03628924. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
ClinicalTrials.gov study NCT06860659. IPD Sharing: NO. Countries: 1. Publications: 23.
Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia
ClinicalTrials.gov study NCT02998645. IPD Sharing: NO. Countries: 9. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.